JP Morgan Chase
AVNS

JP Morgan Chase’s Avanos Medical AVNS Stock Holding History

JP Morgan Chase’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-40,000
Closed -$1.3M – 4533
2016
Q2 		$1.3M Buy
+40,000
New +$1.23M ﹤0.01% 3040

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase's AVNS Position: Q2 2026 in Review

JP Morgan Chase increased its Avanos Medical (AVNS) stake by 338% in Q2 2026, buying an estimated $19.9M and bringing the position to 1,099,770 shares worth $27.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1954.

JP Morgan Chase first reported a position in AVNS in Q4 2014 and has held it in 47 quarters since. The position peaked at $39M in Q4 2017. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • JP Morgan Chase held 1,099,770 shares of Avanos Medical worth $27.4M as of Q2 2026.
  • JP Morgan Chase bought 848,608 Avanos Medical shares in Q2 2026, an estimated $19.9M.
  • Avanos Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1954 holding.
  • JP Morgan Chase first reported a position in Avanos Medical in Q4 2014 and has held it in 47 quarters since.
  • JP Morgan Chase's Avanos Medical position peaked at $39M in Q4 2017.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.